Avalyn Pharma Inc. Common Stock
NASDAQ:AVLNMedical - Pharmaceuticals
Healthcare
$27.69 +1.77%
+$0.52 today
- Market cap
- $1.23B
- Beta
- 0.00
52W Low $24.15High $32.23
Volume 0.40M
Average 0.51M
AVLN Other Non-current Assets
Long-term assets not reported separately.
No reported Other Non-current Assets figures are available to summarize.
Other Non-current Assets history
Currency unavailable · from the balance sheet
No Other Non-current Assets data reported for this period type.
Other Non-current Assets vs competitors
How AVLN compares with its peers on the latest reported figures
AVLN Competitors
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $104.44M USD | +17.6% | +8.6% | 5.0% | |
| Mar 2026 | $10.72M USD | -62.8% | +227.2% | 1.4% | |
| Mar 2026 | $3.34M USD | -39.8% | +54.2% | 2.1% | |
VCREVicore Pharma Holding AB | Jun 2026 | SEK 388.73K SEK | — | — | 0.4% |
AVLNAvalyn Pharma Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding AVLN) | — | -39.8% | +54.2% | 1.8% | |
Competitors are the stored peer set for AVLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Currency unavailable
Avalyn Pharma Inc. Common Stock
NASDAQ:AVLN
Intrinsic Alpha fair value
Locked
Current Price
$27.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.